TY - JOUR PY - 2008 DA - 2008// TI - Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61113-7 DO - 10.1016/S0140-6736(08)61113-7 ID - ref1 ER - TY - JOUR AU - Costagliola, D. PY - 2014 DA - 2014// TI - Demographics of HIV and aging JO - Curr Opin HIV AIDS VL - 9 UR - https://doi.org/10.1097/COH.0000000000000076 DO - 10.1097/COH.0000000000000076 ID - Costagliola2014 ER - TY - JOUR AU - Samji, H. AU - Cescon, A. AU - Hogg, R. S. AU - Modur, S. P. AU - Althoff, K. N. AU - Buchacz, K. PY - 2013 DA - 2013// TI - North American AIDS cohort collaboration on research and design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0081355 DO - 10.1371/journal.pone.0081355 ID - Samji2013 ER - TY - JOUR AU - Nakagawa, F. AU - May, M. AU - Phillips, A. PY - 2013 DA - 2013// TI - Life expectancy living with HIV: recent estimates and future implications JO - Curr Opin Infect Dis VL - 26 UR - https://doi.org/10.1097/QCO.0b013e32835ba6b1 DO - 10.1097/QCO.0b013e32835ba6b1 ID - Nakagawa2013 ER - TY - JOUR AU - Sighem, A. I. AU - Gras, L. A. AU - Reiss, P. AU - Brinkman, K. AU - Wolf, F. PY - 2010 DA - 2010// TI - ATHENA national observational cohort study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals JO - AIDS VL - 24 UR - https://doi.org/10.1097/QAD.0b013e32833a3946 DO - 10.1097/QAD.0b013e32833a3946 ID - Sighem2010 ER - TY - STD TI - DHHS panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Updated on October 25, 2018. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed 3 June 2019. UR - https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf ID - ref6 ER - TY - STD TI - The Guidelines for the Treatment of HIV Infection, March 2019 version. Japanese Ministry of Health, Labour and Welfare. 1–156. Available from: https://www.haart-support.jp/guideline.htm. Accessed 3 June 2019. UR - https://www.haart-support.jp/guideline.htm ID - ref7 ER - TY - JOUR AU - Elzi, L. AU - Marzolini, C. AU - Furrer, H. AU - Ledergerber, B. AU - Cavassini, M. AU - Hirschel, B. PY - 2010 DA - 2010// TI - Swiss HIV cohort study. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 JO - Arch Intern Med VL - 170 UR - https://doi.org/10.1001/archinternmed.2009.432 DO - 10.1001/archinternmed.2009.432 ID - Elzi2010 ER - TY - JOUR AU - Prosperi, M. C. AU - Fabbiani, M. AU - Fanti, I. AU - Zaccarelli, M. AU - Colafigli, M. PY - 2012 DA - 2012// TI - Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study JO - BMC Infect Dis VL - 12 UR - https://doi.org/10.1186/1471-2334-12-296 DO - 10.1186/1471-2334-12-296 ID - Prosperi2012 ER - TY - JOUR AU - Abgrall, S. AU - Ingle, S. M. AU - May, M. T. AU - Costagliola, D. AU - Mercie, P. AU - Cavassini, M. PY - 2013 DA - 2013// TI - Antiretroviral therapy cohort collaboration (ART-CC). Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 JO - AIDS VL - 27 ID - Abgrall2013 ER - TY - STD TI - The Guidelines for the Treatment of HIV Infection, March 2017 version. The Japanese Ministry of Health, Labour and Welfare. 1–152. ID - ref11 ER - TY - JOUR AU - Jarrin, I. AU - Hernández-Novoa, B. AU - Alejos, B. AU - Santos, I. AU - Lopez-Aldeguer, J. AU - Riera, M. PY - 2014 DA - 2014// TI - Cohort of the Spanish HIV research network (CoRIS). Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen JO - HIV Med VL - 15 UR - https://doi.org/10.1111/hiv.12144 DO - 10.1111/hiv.12144 ID - Jarrin2014 ER -